Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2

John R. Benson, Ismail Jatoi

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The 39th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio, Texas, on 9-13 December 2016. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, locoregional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with Part 1 focusing onmetastatic breast cancer, extended endocrine therapy and the prognostic significance of BRCA1/2 gene mutations. The second part of this report will discuss a range of topics including anti-HER2 directed treatments, the impact of radiotherapy on implant and autologous flap based reconstruction, biological risk predictors for ductal carcinoma-in situ (DCIS), longer term effects of dietary fat modification and the influence of aromatase inhibitors on endothelial cell function.

Original languageEnglish (US)
Article number0089
JournalFuture Oncology
Issue number16
StatePublished - Jul 2017


  • San Antonio
  • breast conserving surgery
  • extended endocrine therapy
  • mastectomy
  • radiation treatment
  • reconstruction

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2'. Together they form a unique fingerprint.

Cite this